Information  X 
Enter a valid email address

Judges ScientificPLC (JDG)

  Print          Annual reports

Wednesday 29 June, 2022

Judges ScientificPLC

Director/PDMR Shareholding

RNS Number : 6357Q
Judges Scientific PLC
29 June 2022
 

 

Judges Scientific plc

  ("Judges Scientific", "Judges", the "Company" or the "Group")

  Director/PDMR Shareholding

Judges Scientific, group focused on acquiring and developing companies  in the scientific instrument sector , announces that, Brad Ormsby, Group Finance Director, has today, transferred 536 ordinary shares of 5p each in the Company ("Ordinary Shares") to his and his wife's ISA.

Following the transfer, Brad Ormsby's beneficial interest of 3,831 Ordinary Shares remains unchanged.

 

Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Brad Ormsby

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Finance Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Judges Scientific plc

b)

 

LEI

 

2138004EXWWPTW1JOL31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Judges Scientific plc

 

 

GB0032398678

 

b)

 

Nature of the transaction

 

 

Sale of 536 Ordinary Shares by Mr Ormsby and repurchase of 536 Ordinary Shares (268 Ordinary Shares into Mr Ormsby's ISA and 268 Ordinary Shares into Mrs Ormsby's ISA) in order to effect an ISA transfer

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

7,350p

 

536

 

7,350p

268

7,350p

 

268

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Sale of 536 shares for 7,350p

 

Repurchase of 536 shares for 7,350p

e)

 

Date of the transaction

 

 

29/06/22

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

For further information please contact:

Judges Scientific



David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970


 

Shore Capital (Nominated Adviser & Broker)


Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

William Hall

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

 

Sam Modlin

Justine James

Joe Pederzolli

 

Tel: +44 (0) 20 3405 0205

[email protected]

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector.  The Group now consists of 20 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments.  The Group has received five Queen's Awards for innovation and export. 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash.  Shareholder returns are created through the reduction of debt, organic growth and dividends. 

 

For further information, please visit  www.judges.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDLBBDDGDC

a d v e r t i s e m e n t